HASSE, B., M. M. HANNAN, P. M. KELLER, F. P. MAURER, R. SOMMERSTEIN, D. MERTZ, D. WAGNER, N. FERNANDEZ-HIDALGO, J. NOMURA, V. MANFRIN, D. BETTEX, A. H. CONTE, E. DURANTE-MANGONI, T. H. C. TANG, R. L. STUART, J. LUNDGREN, S. GORDON, M. C. JARASHOW, P. W. SCHREIBER, S. NIEMANN, T. A. KOHL, C. L. DALEY, A. J. STEWARDSON, C. J. WHITENER, K. PERKINS, D. PLACHOURAS, T. LAMAGNI, M. CHAND, Tomáš FREIBERGER, S. ZWEIFEL, P. SANDER, B. SCHULTHESS, J. E. SCRIVEN, H. SAX, J. VAN INGEN, C. A. MESTRES, D. DIEKEMA, B. A. BROWN-ELLIOTT, R. J. WALLACE, L. M. BADDOUR, J. M. MIRO and B. HOEN. International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass. The journal of hospital infection. London: W.B. Saunders, 2020, vol. 104, No 2, p. 214-235. ISSN 0195-6701. Available from: https://dx.doi.org/10.1016/j.jhin.2019.10.009.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass
Authors HASSE, B. (756 Switzerland, guarantor), M. M. HANNAN (372 Ireland), P. M. KELLER (756 Switzerland), F. P. MAURER (276 Germany), R. SOMMERSTEIN (752 Sweden), D. MERTZ (124 Canada), D. WAGNER (276 Germany), N. FERNANDEZ-HIDALGO (724 Spain), J. NOMURA (840 United States of America), V. MANFRIN (380 Italy), D. BETTEX (756 Switzerland), A. H. CONTE (840 United States of America), E. DURANTE-MANGONI (380 Italy), T. H. C. TANG (156 China), R. L. STUART (36 Australia), J. LUNDGREN (208 Denmark), S. GORDON (840 United States of America), M. C. JARASHOW (840 United States of America), P. W. SCHREIBER (756 Switzerland), S. NIEMANN (276 Germany), T. A. KOHL (276 Germany), C. L. DALEY (840 United States of America), A. J. STEWARDSON (36 Australia), C. J. WHITENER (840 United States of America), K. PERKINS (840 United States of America), D. PLACHOURAS (752 Sweden), T. LAMAGNI (826 United Kingdom of Great Britain and Northern Ireland), M. CHAND (826 United Kingdom of Great Britain and Northern Ireland), Tomáš FREIBERGER (203 Czech Republic, belonging to the institution), S. ZWEIFEL (756 Switzerland), P. SANDER (756 Switzerland), B. SCHULTHESS (756 Switzerland), J. E. SCRIVEN (826 United Kingdom of Great Britain and Northern Ireland), H. SAX (756 Switzerland), J. VAN INGEN (528 Netherlands), C. A. MESTRES (756 Switzerland), D. DIEKEMA (840 United States of America), B. A. BROWN-ELLIOTT (840 United States of America), R. J. WALLACE (840 United States of America), L. M. BADDOUR (840 United States of America), J. M. MIRO (840 United States of America) and B. HOEN (250 France).
Edition The journal of hospital infection, London, W.B. Saunders, 2020, 0195-6701.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30303 Infectious Diseases
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.926
RIV identification code RIV/00216224:14110/20:00116158
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.jhin.2019.10.009
UT WoS 000508633400014
Keywords in English Mycobacterial; Mycobacterium chimaera; Cardiopulmonary bypass; Disseminated; Infection; Guidelines; ISCVID; Outbreaks; Heater-cooler device
Tags 14110114, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 10/8/2020 09:40.
Abstract
Mycobacterial infection-related morbidity and mortality in patients following cardiopulmonary bypass surgery is high and there is a growing need for a consensus-based expert opinion to provide international guidance for diagnosing, preventing and treating in these patients. In this document the International Society for Cardiovascular Infectious Diseases (ISCVID) covers aspects of prevention (field of hospital epidemiology), clinical management (infectious disease specialists, cardiac surgeons, ophthalmologists, others), laboratory diagnostics (microbiologists, molecular diagnostics), device management (perfusionists, cardiac surgeons) and public health aspects. (C) 2019 The Author(s). Published by Elsevier Ltd on behalf of The Healthcare Infection Society.
PrintDisplayed: 25/4/2024 19:14